Mary Canning is a Principal with Epidarex Capital. Prior to joining Epidarex in 2013, she had extensive experience in the commercialisation of early-stage health science technologies. As a Business Manager with Medical Research Council Technology (MRCT) she was responsible for the exploitation of intellectual property arising from a number of leading U.K. academic research institutions. She previously worked with the Scottish Enterprise Proof of Concept Programme, building and funding spin-out companies from leading Scottish academic institutions.